356 related articles for article (PubMed ID: 28597042)
41. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
[TBL] [Abstract][Full Text] [Related]
42. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
[TBL] [Abstract][Full Text] [Related]
43. [Synergistic Antitumor Effect of Amorphigenin Combined with Cisplatin in Human Lung Adenocarcinoma A549/DDP Cells].
Zhong H; Zuo Y; Wu X; Peng Y; He H; Yang J; Guan C; Xu Z
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):805-812. PubMed ID: 27978865
[TBL] [Abstract][Full Text] [Related]
44. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
[TBL] [Abstract][Full Text] [Related]
45. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation.
Jin HO; Seo SK; Woo SH; Lee HC; Kim ES; Yoo DH; Lee SJ; An S; Choe TB; Kim JI; Hong SI; Rhee CH; Park IC
Lung Cancer; 2008 Sep; 61(3):317-27. PubMed ID: 18281123
[TBL] [Abstract][Full Text] [Related]
46. Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation.
Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):748-756. PubMed ID: 29961813
[TBL] [Abstract][Full Text] [Related]
47. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
[TBL] [Abstract][Full Text] [Related]
48. Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway.
Wang Z; Ma LJ; Kang Y; Li X; Zhang XJ
Oncol Rep; 2015 Mar; 33(3):1097-106. PubMed ID: 25573172
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of survivin expression and mechanisms of reversing drug-resistance of human lung adenocarcinoma cells by siRNA.
Liu JL; Wang Y; Jiang J; Kong R; Yang YM; Ji HF; Shi YZ
Chin Med J (Engl); 2010 Oct; 123(20):2901-7. PubMed ID: 21034604
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
Chao JI; Kuo PC; Hsu TS
J Biol Chem; 2004 May; 279(19):20267-76. PubMed ID: 14988404
[TBL] [Abstract][Full Text] [Related]
51. Brazilian green propolis induced apoptosis in human lung cancer A549 cells through mitochondrial-mediated pathway.
Frión-Herrera Y; Díaz-García A; Ruiz-Fuentes J; Rodríguez-Sánchez H; Sforcin JM
J Pharm Pharmacol; 2015 Oct; 67(10):1448-56. PubMed ID: 26206395
[TBL] [Abstract][Full Text] [Related]
52. Id4 promotes cisplatin resistance in lung cancer through the p38 MAPK pathway.
Qi K; Li Y; Li X; Lei X; Wang B; Zhang L; Chu X
Anticancer Drugs; 2016 Nov; 27(10):970-8. PubMed ID: 27537399
[TBL] [Abstract][Full Text] [Related]
53. [The effect and mechanism of vinorelbine on cisplatin resistance of human lung cancer cell line A549/DDP].
Qi C; Gao S; Li H; Gao W
Zhongguo Fei Ai Za Zhi; 2014 Feb; 17(2):148-54. PubMed ID: 24581167
[TBL] [Abstract][Full Text] [Related]
54. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
[TBL] [Abstract][Full Text] [Related]
55. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
[TBL] [Abstract][Full Text] [Related]
56. The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells.
Mai L; Luo M; Wu JJ; Yang JH; Hong LY
Neoplasma; 2019 Sep; 66(5):776-784. PubMed ID: 31169018
[TBL] [Abstract][Full Text] [Related]
57. Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel.
Rong F; Li W; Chen K; Li DM; Duan WM; Feng YZ; Li F; Zhou XW; Fan SJ; Liu Y; Tao M
Neoplasma; 2012; 59(5):541-50. PubMed ID: 22668020
[TBL] [Abstract][Full Text] [Related]
58. The effects of combined treatment with sevoflurane and cisplatin on growth and invasion of human adenocarcinoma cell line A549.
Liang H; Wang HB; Liu HZ; Wen XJ; Zhou QL; Yang CX
Biomed Pharmacother; 2013 Jul; 67(6):503-9. PubMed ID: 23639227
[TBL] [Abstract][Full Text] [Related]
59. Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
Tang C; Luo H; Luo D; Yang H; Zhou X
Oncol Rep; 2018 Feb; 39(2):611-618. PubMed ID: 29207183
[TBL] [Abstract][Full Text] [Related]
60. [Effects of bevacizumab and cisplatin on human lung adenocarcinoma A549/DDP xenografts in nude mice].
Dai M; Luo RC; Zheng DY; Lü CW; Ding XM
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1402-5. PubMed ID: 17884788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
